{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T07:23:19Z","timestamp":1773300199640,"version":"3.50.1"},"reference-count":35,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2013,2,5]],"date-time":"2013-02-05T00:00:00Z","timestamp":1360022400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0056046","type":"journal-article","created":{"date-parts":[[2013,2,5]],"date-time":"2013-02-05T22:39:27Z","timestamp":1360103967000},"page":"e56046","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":11,"title":["Long-Term Inhibition of Xanthine Oxidase by Febuxostat Does Not Decrease Blood Pressure in Deoxycorticosterone Acetate (DOCA)-Salt Hypertensive Rats"],"prefix":"10.1371","volume":"8","author":[{"given":"Theodora","family":"Szasz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert Patrick","family":"Davis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hannah S.","family":"Garver","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert J.","family":"Burnett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory D.","family":"Fink","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie W.","family":"Watts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2013,2,5]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1056\/NEJMra0800885","article-title":"Uric acid and cardiovascular risk","volume":"359","author":"DI Feig","year":"2008","journal-title":"N Engl J Med"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1161\/01.HYP.0000069700.62727.C5","article-title":"Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease?","volume":"41","author":"RJ Johnson","year":"2003","journal-title":"Hypertension"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s11906-010-0100-z","article-title":"Oxidative stress and hypertension: current concepts","volume":"12","author":"AM Briones","year":"2010","journal-title":"Curr Hypertens Rep"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1042\/CS20050307","article-title":"Endothelin-1-induced oxidative stress in DOCA-salt hypertension involves NADPH-oxidase-independent mechanisms","volume":"110","author":"GE Callera","year":"2006","journal-title":"Clin Sci (Lond)"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1097\/01.hjh.0000125441.28861.9f","article-title":"Renal xanthine oxidoreductase activity during development of hypertension in spontaneously hypertensive rats","volume":"22","author":"JT Laakso","year":"2004","journal-title":"J Hypertens"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"4754","DOI":"10.1073\/pnas.95.8.4754","article-title":"Xanthine oxidase activity associated with arterial blood pressure in spontaneously hypertensive rats","volume":"95","author":"H Suzuki","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1291\/hypres.31.931","article-title":"Associations of hypertension and its complications with variations in the xanthine dehydrogenase gene","volume":"31","author":"J Yang","year":"2008","journal-title":"Hypertens Res"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1124\/pr.58.1.6","article-title":"Therapeutic effects of xanthine oxidase inhibitors: renaissance half a century after the discovery of allopurinol","volume":"58","author":"P Pacher","year":"2006","journal-title":"Pharmacol Rev"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1080\/15257770802257952","article-title":"Inactivation of nitric oxide by uric acid","volume":"27","author":"C Gersch","year":"2008","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"key":"ref10","first-page":"1929","article-title":"Association between endothelial dysfunction and hyperuricaemia","volume":"49","author":"WJ Ho","year":"2011","journal-title":"Rheumatology (Oxford)"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1111\/j.1523-1755.2005.00273.x","article-title":"Hyperuricemia induces endothelial dysfunction","volume":"67","author":"UM Khosla","year":"2005","journal-title":"Kidney Int"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1161\/hy1101.092839","article-title":"Elevated uric acid increases blood pressure in the rat by a novel crystal-independent mechanism","volume":"38","author":"M Mazzali","year":"2001","journal-title":"Hypertension"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1001\/jama.300.8.924","article-title":"Effect of allopurinol on blood pressure of adolescents with newly diagnosed essential hypertension: a randomized trial","volume":"300","author":"DI Feig","year":"2008","journal-title":"Jama"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1111\/j.1440-1681.2007.04605.x","article-title":"Role of xanthine oxidase in dexamethasone-induced hypertension in rats","volume":"34","author":"SL Ong","year":"2007","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"H281","DOI":"10.1152\/ajpheart.00304.2008","article-title":"Xanthine oxidase and mitochondria contribute to vascular superoxide anion generation in DOCA-salt hypertensive rats","volume":"295","author":"EC Viel","year":"2008","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1291\/hypres.29.915","article-title":"Allopurinol reduces neointimal hyperplasia in the carotid artery ligation model in spontaneously hypertensive rats","volume":"29","author":"Y Yamamoto","year":"2006","journal-title":"Hypertens Res"},{"key":"ref17","first-page":"1241","article-title":"Allopurinol attenuates L-NAME induced cardiomyopathy comparable to blockade of angiotensin receptor","volume":"23","author":"DA Kasal","year":"2008","journal-title":"Histol Histopathol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/j.amjhyper.2005.02.017","article-title":"Apocynin but not allopurinol prevents and reverses adrenocorticotropic hormone-induced hypertension in the rat","volume":"18","author":"Y Zhang","year":"2005","journal-title":"Am J Hypertens"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1161\/01.HYP.0000160404.08866.5a","article-title":"Antioxidant treatment prevents renal damage and dysfunction and reduces arterial pressure in salt-sensitive hypertension","volume":"45","author":"N Tian","year":"2005","journal-title":"Hypertension"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1097\/FJC.0b013e3181f80194","article-title":"Allopurinol does not decrease blood pressure or prevent the development of hypertension in the deoxycorticosterone acetate-salt rat model","volume":"56","author":"T Szasz","year":"2010","journal-title":"J Cardiovasc Pharmacol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1074\/jbc.M208307200","article-title":"An extremely potent inhibitor of xanthine oxidoreductase. Crystal structure of the enzyme-inhibitor complex and mechanism of inhibition","volume":"278","author":"K Okamoto","year":"2003","journal-title":"J Biol Chem"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1016\/j.lfs.2004.10.031","article-title":"Selectivity of febuxostat, a novel non-purine inhibitor of xanthine oxidase\/xanthine dehydrogenase","volume":"76","author":"Y Takano","year":"2005","journal-title":"Life Sci"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1002\/acr.20680","article-title":"Women with gout: efficacy and safety of urate-lowering with febuxostat and allopurinol","volume":"64","author":"S Chohan","year":"2012","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1471-2318-12-11","article-title":"The efficacy and safety of febuxostat for urate lowering in gout patients [greater than or equal to]65 years of age","volume":"12","author":"RL Jackson","year":"2012","journal-title":"BMC Geriatr"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1056\/NEJMoa050373","article-title":"Febuxostat compared with allopurinol in patients with hyperuricemia and gout","volume":"353","author":"MA Becker","year":"2005","journal-title":"N Engl J Med"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1002\/art.24209","article-title":"Effects of febuxostat versus allopurinol and placebo in reducing serum urate in subjects with hyperuricemia and gout: a 28-week, phase III, randomized, double-blind, parallel-group trial","volume":"59","author":"HR Schumacher Jr","year":"2008","journal-title":"Arthritis Rheum"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"98","DOI":"10.3810\/psm.2011.11.1946","article-title":"2011 recommendations for the diagnosis and management of gout and hyperuricemia","volume":"39","author":"M Hamburger","year":"2011","journal-title":"Phys Sportsmed"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"F710","DOI":"10.1152\/ajprenal.00454.2007","article-title":"Effects of febuxostat on metabolic and renal alterations in rats with fructose-induced metabolic syndrome","volume":"294","author":"LG Sanchez-Lozada","year":"2008","journal-title":"Am J Physiol Renal Physiol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"p69","DOI":"10.1159\/000127837","article-title":"Effect of febuxostat on the progression of renal disease in 5\/6 nephrectomy rats with and without hyperuricemia","volume":"108","author":"LG Sanchez-Lozada","year":"2008","journal-title":"Nephron Physiol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1093\/ndt\/gfm783","article-title":"Treatment with the xanthine oxidase inhibitor febuxostat lowers uric acid and alleviates systemic and glomerular hypertension in experimental hyperuricaemia","volume":"23","author":"LG Sanchez-Lozada","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1080\/08037050510008878","article-title":"Effects of allopurinol, a xanthine oxidase inhibitor, on renal injury in hypercholesterolemia-induced hypertensive rats","volume":"14","author":"M Minami","year":"2005","journal-title":"Blood Press"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.2165\/00003495-200868130-00006","article-title":"Febuxostat","volume":"68","author":"PI Hair","year":"2008","journal-title":"Drugs"},{"key":"ref33","first-page":"343","article-title":"Increased reactive oxygen species contributes to kidney injury in mineralocorticoid hypertensive rats","volume":"57","author":"L Jin","year":"2006","journal-title":"J Physiol Pharmacol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"H1891","DOI":"10.1152\/ajpheart.00655.2010","article-title":"2,3',4,5'-Tetramethoxystilbene prevents deoxycorticosterone-salt-induced hypertension: contribution of cytochrome P-450 1B1","volume":"299","author":"S Sahan-Firat","year":"2010","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1161\/01.HYP.0000112304.26158.5c","article-title":"Tempol lowers blood pressure and sympathetic nerve activity but not vascular O2- in DOCA-salt rats","volume":"43","author":"H Xu","year":"2004","journal-title":"Hypertension"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0056046","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,20]],"date-time":"2018-10-20T03:33:51Z","timestamp":1540006431000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0056046"}},"subtitle":[],"editor":[{"given":"Harald H.H.W.","family":"Schmidt","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2013,2,5]]},"references-count":35,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2013,2,5]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0056046","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,2,5]]}}}